Form 8-K - Current report:
SEC Accession No. 0001104659-20-132147
Filing Date
2020-12-04
Accepted
2020-12-03 21:38:01
Documents
13
Period of Report
2020-11-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2037374d2_8k.htm   iXBRL 8-K 33123
2 EXHIBIT 10.1 tm2037374d2_ex10-1.htm EX-10.1 46302
  Complete submission text file 0001104659-20-132147.txt   268496

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA immu-20201130.xsd EX-101.SCH 3186
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20201130_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20201130_pre.xml EX-101.PRE 22710
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2037374d2_8k_htm.xml XML 3602
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 201368470
SIC: 2834 Pharmaceutical Preparations